Contact Us
Drug Search Results
More Filters [+]

Eszopiclone

Alternative Names: eszopiclone, lunesta
Latest Update: 2024-07-18
Latest Update Note: News Article

Product Description

Eszopiclone is used to treat insomnia (difficulty falling asleep or staying asleep). Eszopiclone is in a class of medications called hypnotics. It works by slowing activity in the brain to allow sleep. (Sourced from: https://medlineplus.gov/druginfo/meds/a605009.html)

Mechanisms of Action: GABA Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Czech | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Hungary | India | Italy | Japan | Korea | Latvia | Lebanon | Lithuania | Pakistan | Peru | Poland | Saudi Arabia | Slovakia | Taiwan | United Arab Emirates | United States | Uruguay | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Eisai
Company Location: BUNKYO-KU TOKOYO 112 M0
Company CEO: Haruo Naito
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Eszopiclone

Countries in Clinic: India

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Acute Respiratory Distress Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
HP8821-01

P1

Completed

Acute Respiratory Distress Syndrome

2022-04-19

53%

Recent News Events

Date

Type

Title

07/18/2024

News Article

 Sleeping Pills Market to Reach USD 132.31 Billion by 2032, Growing at a 5.5% CAGR, Reports Straits Research

10/04/2023

News Article

 Aerospace And Defense Brakes Market - by Component, Type, Enterprise Size, Application, End-use Industry, and Region - to 2030

09/28/2023

News Article

 Sedative-Hypnotic Drugs Market Size, Share and Forecast 2031

09/27/2023

News Article

 Sleeping Pills Market Application, Development, Segment 2030

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions